Fundraising FoxMorphoceuticals
Medford, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into Morphoceuticals
Sign up to see every warm intro you have to Morphoceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Morphoceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Morphoceuticals is a TechBio company mapping the "bioelectrome" — the body's cellular communication networks that govern tissue repair and organ regeneration. It combines multi-omics, bioelectric profiling, and AI to modulate ion channels for applications in regenerative medicine.
Founders & leadership
Board
AP
Alexander PickettBoard director
JB
Justin BriggsBoard MemberScientist, entrepreneur, and investor building companies at the nexus of biology, chemistry, and engineering
TH
Tamim Hamad J.J Al-ThaniBoard director
AK
RH
Rosemarie HunzikerBoard director
Investors · 1
Prime Movers LabreportedJackson · $2M – $30Mvia Amy Kruse · board
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · press coverage · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$13.3M disclosed across 2 rounds · 2023–2024
▶$3.5MraisedOct 2024 · 1 investors · BiotechnologyRule 506(b)
▶$3.5MraisedOct 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael R. HuffordDirector
- Alexander PickettDirector
- Justin BriggsDirector
- Tamim Hamad J.J Al-ThaniDirector
- Rosemarie HunzikerDirector
- James JensonExecutive Officer, Director
- Offering amount
- $5.5M
- Amount sold
- $3.5M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$9.8MraisedJan 2023 · 3 investors · BiotechnologyRule 506(b)
▶$9.8MraisedJan 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander PickettDirector
- Michael LevinPromoter
- David GillExecutive Officer
- David KaplanPromoter
- Amy KruseDirector
- Michael R. HuffordExecutive Officer, Director
- Rosemarie HunzikerDirector
- Offering amount
- $9.8M
- Amount sold
- $9.8M
- Proceeds to insiders
- $612K
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
nChroma BionChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.
MetaphorebioMetaphore develops a platform that measures biological activity inside cells at scale to design antibody medicines with novel mechanisms of action. The company aims to create antibodies that activate pathways, modulate signaling, and engage multiple targets to treat complex diseases.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as Morphoceuticals.
In the news
Frequently asked questions
- What does Morphoceuticals do?
- Morphoceuticals is a TechBio company mapping the "bioelectrome" — the body's cellular communication networks that govern tissue repair and organ regeneration. It combines multi-omics, bioelectric profiling, and AI to modulate ion channels for applications in regenerative medicine.
- Who are Morphoceuticals's investors?
- Morphoceuticals's investors include Prime Movers Lab.
- How much funding has Morphoceuticals raised?
- Morphoceuticals has disclosed $13.3M raised across 2 rounds.
- Where is Morphoceuticals headquartered?
- Morphoceuticals is headquartered in Medford, US.